B

BioEclipse Therapeutics, Inc

9 employees

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.

Basic info

Industry

biotechnology research

Sectors

immuno-therapy
Biotechnology
Health Care
Therapeutics
cancer
start-up
oncology
biotech

Date founded

2017

Funding rounds raised

Total raised

$7.7M

from 7 investors over 7 rounds

B

BioEclipse Therapeutics, Inc raised $7.7M on June 24, 2019

Investors: Revelis Capital Group, DEFTA Partners, TSVC, Foothill Ventures and Plum Alley Investments

B

BioEclipse Therapeutics, Inc raised undisclosed on January 30, 2018

Investors: Plum Alley Investments

B

BioEclipse Therapeutics, Inc raised undisclosed on July 20, 2016

Investors: TSVC

FAQ